Prevalence of mutations conferring resistance among multi- and extensively drug-resistant Mycobacterium tuberculosis isolates in China.

Chen, Yan; Zhao, Bing; Liu, Hai-can; Sun, Qing; Zhao, Xiu-qin; Liu, Zhi-guang; Wan, Kang-lin; Zhao, Li-li

Chen, Yan; Zhao, Bing; Liu, Hai-can; Sun, Qing; Zhao, Xiu-qin; Liu, Zhi-guang; Wan, Kang-lin; Zhao, Li-li.

Afiliação

Chen Y; State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhao B; Beijing Chest Hospital, Capital Medical University, Beijing, China.
Liu HC; National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Sun Q; State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhao XQ; State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Liu ZG; Pathogenic Biology Institute, University of South China, Hunan Province, China.
Wan KL; State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhao LL; State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

J Antibiot (Tokyo) ; 69(3): 149-52, 2016 Mar.

Article em En | MEDLINE | ID: mdl-26486879

Assuntos

Farmacorresistência Bacteriana Múltipla/genética; Tuberculose Extensivamente Resistente a Medicamentos/microbiologia; Genes Bacterianos; Mycobacterium tuberculosis/efeitos dos fármacos; Mycobacterium tuberculosis/genética; Antituberculosos/farmacologia; Proteínas de Bactérias/genética; Proteínas de Bactérias/metabolismo; Catalase/genética; Catalase/metabolismo; China; DNA Bacteriano/genética; RNA Polimerases Dirigidas por DNA/genética; RNA Polimerases Dirigidas por DNA/metabolismo; Tuberculose Extensivamente Resistente a Medicamentos/diagnóstico; Tuberculose Extensivamente Resistente a Medicamentos/tratamento farmacológico; Loci Gênicos; Humanos; Isoniazida/farmacologia; Ofloxacino/farmacologia; Oxirredutases/genética; Oxirredutases/metabolismo; Rifampina/farmacologia; Análise de Sequência de DNA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana Múltipla / Tuberculose Extensivamente Resistente a Medicamentos / Genes Bacterianos / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Antibiot (Tokyo) Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google